Case Study

Owlstone Medical

Owlstone’s mission is to save 100,000 lives and save health care providers $1.5B.

The team have developed patented technology which uses breath to analyse disease biomarkers. This enables non-invasive diagnostics for cancer, infectious and inflammatory diseases.

The company has a clear alignment to our health business and our focus on wellness and prevention.
Ben Luckett, Managing Director, Aviva Ventures

A deeper understanding of new and innovative technologies that detect disease will deliver greater insights into our health business and help us develop new products for our customers.

To learn more visit: https://www.owlstonemedical.com

Back to Aviva Ventures home page

Case Studies

Shepper

Shepper carries out Smart Asset Checks on properties and assets.

Find out more

Ben Luckett

Managing Director, Aviva Ventures

Read more

Ant Barker

Head of Portfolio Management, Aviva Ventures

Read more

Pallavi Reddy

Head of Ventures Investments, Aviva Ventures

Read more

Partner with us

If you'd like to explore partnership opportunities for your start-up with Aviva, email us:

Partnership enquiry

Investment opportunities

If you’re a start-up looking for a strategic investor, we would like to hear from you.

Investment enquiry

Join the team

If you'd like to join the digital team at Aviva please visit our careers site.

Go to careers site

Follow us on Twitter

If you'd like to keep up to date on Aviva’s corporate venture capital fund news follow us at:

@avivaventures